3-(2-butyl-1,3-dioxan-2-yl)-N~1~-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-N~2~-(methoxycarbonyl)-D-alaninamide | 477793-74-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-(2-butyl-1,3-dioxan-2-yl)-N~1~-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-N~2~-(methoxycarbonyl)-D-alaninamide
• 英文别名: methyl N-[(2R)-3-(2-butyl-1,3-dioxan-2-yl)-1-[[(2S,3R)-1-(3,5-difluorophenyl)-4-[(3-ethylphenyl)methylamino]-3-hydroxybutan-2-yl]amino]-1-oxopropan-2-yl]carbamate
• CAS: 477793-74-1
• 化学式: C₃₂H₄₅F₂N₃O₆
• 分子量: 605.723
• InChiKey: FDFWBQXKCQGVIU-ZGIBFIJWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  43
• 可旋转键数：
  17
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  118
• 氢给体数：
  4
• 氢受体数：
  9

文献信息

• Hydroxy Alkyl Amines
  申请人：Freskos John

  公开号：US20070299263A1

  公开（公告）日：2007-12-27

  Disclosed are compounds of formula X, which are useful in treating Alzheimer's disease and other similar diseases. Pharmaceutical compositions comprising compounds of formula X and methods of preparing the compounds of formula X are also disclosed.

  本发明涉及一种公式X的化合物，其可用于治疗阿尔茨海默病和其他类似疾病。本发明还涉及包含公式X化合物的制药组合物以及制备公式X化合物的方法。
• HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES
  申请人：Elan Pharmaceuticals, Inc.

  公开号：EP1395551A2

  公开（公告）日：2004-03-10
• US7144897B2
  申请人：——

  公开号：US7144897B2

  公开（公告）日：2006-12-05
• [EN] HYDROXY ALKYL AMINES<br/>[FR] HYDROXYALKYLAMINES
  申请人：ELAN PHARM INC

  公开号：WO2002098849A2

  公开（公告）日：2002-12-12

  Disclosed are compounds of formula X, where Rn, R20, R1, R2, R3, and Rc are defined herein. These compounds are useful in treating Alzheimer's disease and other similar diseases. Pharmaceutical compositions comprising compounds of formula X and methods of preparing the compounds of formula X are also disclosed.